Company: DVAX
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049536
Chunk: 290

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 290
---
030 2,347 197,377 Other revenue10,903 794 11,697 7,663 174 7,837 Total revenues$256,066 $2,416 $258,482 $202,693 $2,521 $205,214 Revenues from Major Customers and Collaboration PartnersHEPLISAV-B product sales in the U.S. are to certain wholesalers and specialty distributors whose customers include integrated delivery networks, retail pharmacies, independent hospitals and clinics, public health clinics and prisons, the Department of Defense, and the Department of Veterans Affairs. 

20

In May 2021, we entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV-B in Germany, and in May 2022, we commenced commercial shipments of HEPLISAV-B in Germany. In the second quarter of 2025, the commercialization agreement was not renewed. Bavarian Nordic will retain the distribution rights for HEPLISAV-B in Germany through April 2026, after which Dynavax will regain the commercialization rights. We do not currently market HEPLISAV-B outside the U.S.The following table summarizes HEPLISAV-B product revenue from each of our three largest customers (as a percentage of total HEPLISAV-B product revenue): Three Months EndedSeptember 30,Nine Months EndedSeptember 30, 2025202420252024Largest customer33%31%30%29%Second largest customer21%20%20%21%Third largest customer21%19%20%18%Contract BalancesThe following table summarizes balances and activities in HEPLISAV-B product revenue allowance and reserve categories for the nine months ended September 30, 2025 (in thousands): Balance atBeginningof PeriodProvisionsrelated tocurrentperiod salesCredit orpaymentsmade duringthe periodAdjustments (3)Balanceat End ofPeriodNine months ended September 30, 2025:Accounts receivable reserves (1)$9,317 $69,176 $(66,495)$(2)$11,996 Revenue reserve accruals (2)$31,479 $46,346 $(42,590)$(11,187)$24,048 (1)Reserves are for chargebacks, discounts and other fees.(2)Accruals are for returns, rebates and other fees.(3)Adjustments for $11.2 million primarily from a change